FDA Narrows Potency Standards For Levothyroxine: New rules require 95%-105% potency.

The Food and Drug Administration has tightened the potency specifications required for levothyroxine sodium products, mandating that they cannot lose more than 5% of their baseline potency by the time they reach their expiration date.